Computer-Aided Drug Designing Illuminate Polypharmacology of Natural Products Against Multiple Estrogen Receptor

dc.contributor.authorKhan, Shafi Ullah
dc.contributor.authorKhan, Ashraf Ullah
dc.contributor.authorKamal, Mohammad Amjad
dc.contributor.authorHtar, Thet Thet
dc.date.accessioned2024-05-08T09:07:57Z
dc.date.available2024-05-08T09:07:57Z
dc.date.issued2023-06-15
dc.description.abstractDrug development is the process of bringing a new drug to market after a lead chemical has been identified through drug discovery. Before a medicine is available for clinical use, the drug development process can take up to 20 years and cost as much as $3 billion USD. Finding a single molecule for multiple targets, also known as polypharmacology or multitarget drug (MTD), can be a time- and cost-efficient technique for drug development. In addition, the application of computer-aided drug design techniques in drug development can reduce drug development expenditures and shorten the drug development cycle in comparison to conventional drug development. This chapter focused on methods for identifying polypharmacological compounds with multiple targets. A step-by-step case study for identifying a multitarget drug to treat breast cancer is also provided.
dc.identifier.otherhttp://dspace.daffodilvarsity.edu.bd:8080/handle/123456789/12291
dc.identifier.urihttp://dspace.daffodilvarsity.edu.bd:8080/handle/123456789/12291
dc.language.isoen_US
dc.publisherElsevier
dc.sourceDIU Institutional Repository
dc.subjectDrug discovery
dc.subjectBreast cancer
dc.subjectPharmacology
dc.titleComputer-Aided Drug Designing Illuminate Polypharmacology of Natural Products Against Multiple Estrogen Receptor
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Computer-Aided Drug Designing Illuminate Polypharmacology of Natural Products Against Multiple Estrogen Receptor.docx
Size:
13.81 KB
Format:
Adobe Portable Document Format

Collections